News

December 13, 2012 — St. Jude Medical Inc. announced the first patient implant of its 23 mm Portico transcatheter aortic heart valve using the transapical delivery system.

Medtronic Inc. announced the first treatment of a U.S. patient in its global, multicenter, randomized clinical trial comparing the Medtronic CoreValve system with surgical aortic valve replacement...

Heart Valve Edwards Lifesciences Medtronic Corevalve

The U.S. Court of Appeals for the Federal Circuit affirmed an April 2010 federal jury decision that Medtronic CoreValve LLC is willfully infringing  Edwards Lifesciences' U.S. Andersen...

Corindus CorPath robotic system

Hospitals constantly try to predict what the future holds when planning new facilities and equipment purchases that need to last for the next decade. Martin Leon, M.D., attempted to answer that...

Medtronic CoreValve  CoreValve ADVANCE Study

Medtronic Inc. announced new findings from the Medtronic CoreValve ADVANCE Study for one-year survival and health-related quality of life (HRQoL). The findings were presented at Transcatheter...

Edwards Sapien Valve Partner Clinical Trial Heart Valve Repair

Edwards Lifesciences Corporation announced three-year results of a pivotal clinical study of inoperable patients with severe aortic stenosis treated with the Edwards Sapien transcatheter heart...

DISCOVER Clinical Trial Direct Medical Trial Direct Flow Medical Transcatheter

Direct Flow Medical Inc. announced that its DISCOVER CE mark trial met its primary mortality endpoint. The study also demonstrated that greater than 95 percent of patients had mild or less aortic...

Engager TAVI Device Medtronic Inc Heart Valve Repair Clinical Study

Medtronic Inc. announced promising data from the Engager European Pivotal Trial for the investigational Medtronic Engager transcatheter aortic valve implantation (TAVI) system. The first results...

The Transcatheter Cardiovascular Therapeutics (TCT) conference showcases key advancements being made in interventional cardiology, focusing this year on the next generation of drug-eluting stents...

Edwards Lifesciences announced today it received approval from the United States Food and Drug Administration (FDA) to treat high-risk aortic stenosis patients with the Edwards Sapien...

October 12, 2012 — Boston Scientific announced it has enrolled the first patient in the REPRISE II clinical trial to evaluate the safety and performance of the Lotus valve system in up to 120...

Medtronic Inc. CoreValve Evolut Heart Valve Repair

Medtronic Inc. announced it has received CE mark for its Medtronic CoreValve Evolut 23 mm valve, its latest self-expanding transcatheter aortic valve implantation (TAVI) system.

September 19, 2012 — In response to criticism by physicians about the restrictiveness of conditions put forth by the Center for Medicare and Medicaid Services (CMS) for reimbursement for...

Tiara transcatheter mitral valve

September 18, 2012 — Neovasc Inc. announced that acute results from preclinical studies of its Tiara valve for the transcatheter treatment of mitral regurgitation were published in the ...

ESC Heart Valve Repair Hybrid OR Clinical trial/study

Cardiologists are restricting the use of transcatheter aortic valve implantation (TAVI) to very old or very sick patients at high surgical risk, according to research presented at the European...

The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report investigations that will be presented at next month's ...

Medtronic has reached two clinical program milestones for its CoreValve system in the United States. It completed enrollment in its study of high-risk patients in its CoreValve U.S. Pivotal...

Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR), a new startup company has developed a transfemoral combined access and...

Trends and new technology for cardiac computed tomography angiography (CCTA) were highlighted during the 2012 Society of Cardiovascular CT (SCCT) annual scientific meeting in July in Baltimore, Md...

July 23, 2012 — Medtronic Inc. announced the first patient enrollment in a clinical trial comparing the CoreValve system with surgical aortic valve replacement in patients with severe aortic...